Nanoparticles integrating natural and synthetic polymers for in vivo insulin delivery

References

• Abdelkader A, El-Mokhtar MA, Abdelkader O, Hamad MA, Elsabahy M, El-Gazayerly ON. 2017. Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model. Carbohydr Polym. 174:1041–1050.
   PubMed Web of Science ®Google Scholar
• Abeeleh MA, Ismail ZB, Alzaben KR, Abu-Halaweh SA, Al-Essa MK, Abuabeeleh J, Alsmady MM. 2009. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. Eur J Sci Res. 32(3):398–402.
   Google Scholar
• Al-Qadi S, Grenha A, Carrion-Recio D, Seijo B, Remunan-Lopez C. 2012. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release. 157(3):383–390.
   PubMed Web of Science ®Google Scholar
• Andreani T, Miziara L, Lorenzon EN, de Souza AL, Kiill CP, Fangueiro JF, Garcia ML, Gremiao PD, Silva AM, Souto EB. 2015. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: interactions with mucin and biomembrane models. Eur J Pharm Biopharm. 93:118–126.
   PubMed Web of Science ®Google Scholar
• Arbit E, Kidron M. 2009. Oral insulin: the rationale for this approach and current developments. J Diabetes Sci Technol. 3(3):562–567.
   PubMedGoogle Scholar
• Arora S, Gupta S, Narang RK, Budhiraja RD. 2011. Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for H. Pylori. Sci Pharm. 79(3):673–694.
   PubMedGoogle Scholar
• Aschner PM, Muñoz OM, Girón D, García OM, Fernández-Ávila DG, Casas LÁ, Bohórquez LF, Arango T CM, Carvajal L, Ramírez DA, et al. 2016. Clinical practice guideline for the prevention, early detection, diagnosis, management and follow up of type 2 diabetes mellitus in adults. Colomb Med. 47(2):109–131.
   PubMed Web of Science ®Google Scholar
• Azevedo J, Sizilio R, Brito M, Costa A, Serafini M, Araújo A, Santos M, Lira A, Nunes R. 2011. Physical and chemical characterization insulin-loaded chitosan-TPP nanoparticles. J Therm Anal Calorim. 106(3):685–689.
   Web of Science ®Google Scholar
• Baharifar H, Amani A. 2017. Size, loading efficiency, and cytotoxicity of albumin-loaded chitosan nanoparticles: an artificial neural networks study. J Pharm Sci. 106(1):411–417.
   PubMed Web of Science ®Google Scholar
• Boonsongrit Y, Mueller BW, Mitrevej A. 2008. Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry. Eur J Pharm Biopharm. 69(1):388–395.
   PubMed Web of Science ®Google Scholar
• Daemi H, Barikani M. 2012. Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles. Scientia Iranica. 19(6):2023–2028.
   Web of Science ®Google Scholar
• Das N, Madan P, Lin S. 2010. Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels. Pharm Dev Technol. 15(2):192–208.
   PubMed Web of Science ®Google Scholar
• Das N, Madan P, Lin S. 2012. Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin. Pharm Dev Technol. 17(3):363–374.
   PubMed Web of Science ®Google Scholar
• de Fine Olivarius N, Andreasen AH. 1997. Five-year all-cause mortality of 1323 newly diagnosed middle-aged and elderly diabetic patients. Data from the population-based study, diabetes care in general practice, Denmark. J Diabetes Complications. 11(2):83–89.
   PubMed Web of Science ®Google Scholar
• Desai SD, Blanchard J. 1998. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci. 87(2):226–230.
   PubMed Web of Science ®Google Scholar
• Elgindy N, Elkhodairy K, Molokhia A, ElZoghby A. 2011. Biopolymeric nanoparticles for oral protein delivery: design and in vitro evaluation. J Nanomed Nanotechnol. 2(3):110.
   Google Scholar
• Elsabahy M, Wooley KL. 2015. Data mining as a guide for the construction of cross-linked nanoparticles with low immunotoxicity via control of polymer chemistry and supramolecular assembly. Acc Chem Res. 48(6):1620–1630.
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Zhang M, Gan SM, Waldron KC, Leroux JC. 2008. Synthesis and enzymatic stability of PEGylated oligonucleotide duplexes and their self-assemblies with polyamidoamine dendrimers. Soft Matter. 4(2):294–302.
   PubMed Web of Science ®Google Scholar
• Fathi HA, Abdelkader A, AbdelKarim MS, Abdelaziz AA, El-Mokhtar MA, Allam A, Fetih G, El Badry M, Elsabahy M. 2020. Electrospun vancomycin-loaded nanofibers for management of methicillin-resistant Staphylococcus aureus-induced skin infections. Int J Pharm. 586:119620
   PubMed Web of Science ®Google Scholar
• Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. 2018. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces. 162:236–245.
   PubMed Web of Science ®Google Scholar
• Feasby WR. 1958. The discovery of insulin. J Hist Med Allied Sci. 13(1):68–84.
   PubMedGoogle Scholar
• Golla R, Seethala R. 2004. A sensitive, robust high-throughput electrochemiluminescence assay for rat insulin. J Biomol Screen. 9(1):62–70.
   PubMedGoogle Scholar
• Green A, Hougaard P. 1984. Epidemiological studies of diabetes mellitus in Denmark: 5. Mortality and causes of death among insulin-treated diabetic patients. Diabetologia. 26(3):190–194.
   PubMed Web of Science ®Google Scholar
• Grigoras AG. 2017. Polymer-lipid hybrid systems used as carriers for insulin delivery. Nanomedicine. 13(8):2425–2437.
   PubMed Web of Science ®Google Scholar
• Gupta VK, Karar P. 2011. Optimization of process variables for the preparation of chitosan-alginate nanoparticles. Int J Pharm Pharm Sci. 3:78–80.
   Google Scholar
• Hadiya S, Liu X, Abd El-Hammed W, Elsabahy M, Aly SA. 2018. Levofloxacin-loaded nanoparticles decrease emergence of fluoroquinolone resistance in Escherichia coli. Microb Drug Resist. 24(8):1098–1107.
   PubMed Web of Science ®Google Scholar
• Heinemann L. 2010. Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy? J Diabetes Sci Technol. 4(3):750–753.
   PubMedGoogle Scholar
• Herrero EP, Alonso MJ, Csaba N. 2012. Polymer-based oral peptide nanomedicines. Ther Deliv. 3(5):657–668.
   PubMedGoogle Scholar
• Hosseinzadeh H, Atyabi F, Dinarvand R, Ostad SN. 2012. Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomed. 7:1851.
   PubMed Web of Science ®Google Scholar
• Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, Exner AA. 2010. Formulation and characterization of echogenic lipid-Pluronic nanobubbles. Mol Pharm. 7(1):49–59.
   PubMed Web of Science ®Google Scholar
• Lawrie G, Keen I, Drew B, Chandler-Temple A, Rintoul L, Fredericks P, Grøndahl L. 2007. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules. 8(8):2533–2541.
   PubMed Web of Science ®Google Scholar
• Li L, Jiang G, Yu W, Liu D, Chen H, Liu Y, Tong Z, Kong X, Yao J. 2017. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Mater Sci Eng C Mater Biol Appl. 70(Pt 1):278–286.
   PubMed Web of Science ®Google Scholar
• Li T, Shi XW, Du YM, Tang YF. 2007. Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res A. 83(2):383–390.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhou C, Xia X, Liu Y. 2016. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Int J Nanomedicine. 11:761–769.
   PubMed Web of Science ®Google Scholar
• Lopes M, Derenne A, Pereira C, Veiga F, Seiça R, Sarmento B, Ribeiro A. 2016. Impact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorption. RSC Adv. 6(24):20155–20165.
   Web of Science ®Google Scholar
• Ma Z, Yeoh HH, Lim LY. 2002. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci. 91(6):1396–1404.
   PubMed Web of Science ®Google Scholar
• Mekkawy AI, El-Mokhtar MA, Nafady NA, Yousef N, Hamad MA, El-Shanawany SM, Ibrahim EH, Elsabahy M. 2017. In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels. Int J Nanomedicine. 12:759–777.
   PubMed Web of Science ®Google Scholar
• Misbin RI, Almira EC. 1989. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin. Diabetes. 38(2):152–158.
   PubMed Web of Science ®Google Scholar
• Nashaat D, Elsabahy M, El-Sherif T, Hamad MA, El-Gindy GA, Ibrahim EH. 2019. Development and in vivo evaluation of chitosan nanoparticles for the oral delivery of albumin. Pharm Dev Technol. 24(3):329–337.
   PubMed Web of Science ®Google Scholar
• Owens DR, Zinman B, Bolli G. 2003. Alternative routes of insulin delivery. Diabet Med. 20(11):886–898.
   PubMed Web of Science ®Google Scholar
• Patil NH, Devarajan PV. 2016. Insulin-loaded alginic acid nanoparticles for sublingual delivery. Drug Deliv. 23(2):429–436.
   PubMed Web of Science ®Google Scholar
• Pepic I, Jalsenjak N, Jalsenjak I. 2004. Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm. 272(1–2):57–64.
   PubMed Web of Science ®Google Scholar
• Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. 1993. Development of a new drug carrier made from alginate. J Pharm Sci. 82(9):912–917.
   PubMed Web of Science ®Google Scholar
• Samarajeewa S, Ibricevic A, Gunsten SP, Shrestha R, Elsabahy M, Brody SL, Wooley KL. 2013. Degradable cationic shell cross-linked knedel-like nanoparticles: synthesis, degradation, nucleic acid binding, and in vitro evaluation. Biomacromolecules. 14(4):1018–1027.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga F, Ribeiro A. 2006. Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym. 66(1):1–7.
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D. 2006. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces. 53(2):193–202.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. 2007. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res. 24(12):2198–2206.
   PubMed Web of Science ®Google Scholar
• Shahani S, Shahani L. 2015. Use of insulin in diabetes: a century of treatment. Hong Kong Med J. 21(6):553–559.
   PubMed Web of Science ®Google Scholar
• Shaji J, Shaikh M. 2016. Formulation, optimization, and characterization of biocompatible inhalable d-cycloserine-loaded alginate-chitosan nanoparticles for pulmonary drug delivery. Asian J Pharm Clin Res. 9(2):82–95.
   Google Scholar
• Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. 2009. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials. 30(12):2329–2339.
   PubMed Web of Science ®Google Scholar
• Sun L, Zhang X, Wu Z, Zheng C, Li C. 2014. Oral glucose-and pH-sensitive nanocarriers for simulating insulin release in vivo. Polym Chem. 5(6):1999–2009.
   Web of Science ®Google Scholar
• Tomar L, Tyagi C, Kumar M, Kumar P, Singh H, Choonara YE, Pillay V. 2013. In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit model. Int J Nanomedicine. 8:505–520.
   PubMed Web of Science ®Google Scholar
• Tong Z, Zhou J, Zhong J, Tang Q, Lei Z, Luo H, Ma P, Liu X. 2018. Glucose- and H2O2-responsive polymeric vesicles integrated with microneedle patches for glucose-sensitive transcutaneous delivery of insulin in diabetic rats. ACS Appl Mater Interfaces. 10(23):20014–20024.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Chandalia HB, Rao PV, Badgandi M, Patni R, Subbanna PK, Shetty R, Kumar H. 2011. Improved glycaemic control with no weight gain: a 26-week, open label, non-randomised, non-interventional observational study on type 2 diabetes subjects using insulin detemir. J Indian Med Assoc. 109(4):275–278.
   PubMedGoogle Scholar
• Wang J, Kong M, Zhou Z, Yan D, Yu X, Cheng X, Feng C, Liu Y, Chen X. 2017. Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery. Carbohydr Polym. 157:596–602.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li P, Kong L. 2013. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. Aaps Pharmscitech. 14(2):585–592.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Veiga F, Ribeiro A, Neufeld R. 2009. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin. Eur J Pharm Biopharm. 73(1):25–33.
   PubMed Web of Science ®Google Scholar
• Wong CY, Al-Salami H, Dass CR. 2017. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 264:247–275.
   PubMed Web of Science ®Google Scholar
• Wu ZM, Ling L, Zhou LY, Guo XD, Jiang W, Qian Y, Luo KQ, Zhang LJ. 2012. Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery. Nanoscale Res Lett. 7(1):299.
   PubMed Web of Science ®Google Scholar
• Wu JZ, Williams GR, Li HY, Wang D, Wu H, Li SD, Zhu LM. 2017. Glucose- and temperature-sensitive nanoparticles for insulin delivery. Int J Nanomedicine. 12:4037–4057.
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 250(1):215–226.
   PubMed Web of Science ®Google Scholar
• Yu F, Li Y, Liu CS, Chen Q, Wang GH, Guo W, Wu XE, Li DH, Wu WD, Chen XD. 2015. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int J Pharm. 484(1–2):181–191.
   PubMed Web of Science ®Google Scholar
• Zhang F, Elsabahy M, Zhang S, Lin LY, Zou J, Wooley KL. 2013. Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking. Nanoscale. 5(8):3220–3225.
   PubMed Web of Science ®Google Scholar
• Zhang N, Li J, Jiang W, Ren C, Xin J, Li K. 2010. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm. 393(1–2):212–218.
   PubMed Web of Science ®Google Scholar